Voleon Capital Management LP Sarepta Therapeutics, Inc. Transaction History
Voleon Capital Management LP
- $4.09 Trillion
- Q3 2025
A detailed history of Voleon Capital Management LP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Voleon Capital Management LP holds 501,142 shares of SRPT stock, worth $9.43 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
501,142
Previous 10,547
4651.51%
Holding current value
$9.43 Million
Previous $180 Million
5254.47%
% of portfolio
0.24%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding SRPT
# of Institutions
408Shares Held
83.7MCall Options Held
5.27MPut Options Held
5.94M-
Vanguard Group Inc Valley Forge, PA10.8MShares$203 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$194 Million0.04% of portfolio
-
State Street Corp Boston, MA5.3MShares$99.8 Million0.0% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.69MShares$50.5 Million0.49% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.65MShares$49.8 Million0.07% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.65B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...